Avenue Therapeutics, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.56 USD | -4.04% |
|
+5.01% | -70.52% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.52% | 3.35M | |
+16.42% | 122B | |
+19.02% | 113B | |
+3.14% | 22.66B | |
-16.20% | 21.34B | |
-39.57% | 16.92B | |
-11.63% | 16.68B | |
-16.15% | 16.61B | |
+2.68% | 13.62B | |
+21.16% | 11.04B |
- Stock Market
- Equities
- ATXI Stock
- News Avenue Therapeutics, Inc.
- Avenue Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt